Skip to content

HerMD is on a mission to close the gender gap in healthcare.

Women make up half of the world’s population, yet, only 1% of the $200B spent on healthcare research to improve treatment solutions goes toward women’s health. Yes, that’s right.

Another fact: there are only 2 FDA-approved medications for hypoactive sexual desire disorder (HSDD or low libido), while men have 26 for erectile dysfunction alone. With research, we can start to close the gender gap in health care and give women more FDA-approved treatment options that are covered by insurance, making them more cost-effective and finally making treatment options more accessible to more people.

Interested in partnering with us on a research trial to advance women’s health care? 


Our Clinical Research

Botulinum Toxin (Botox®) for the Treatment of Vaginismus

Utilizing Advanced, Innovative Technologies To Improve Symptoms Associated with Sexual Health and Menopause Conditions

Fractional CO2 laser treatment

as adjunctive therapy to topical steroids for managing vulvar lichen sclerosus.

Evaluation of flibanserin’s benefits

and tolerability in women with low libido and a history of breast cancer.


Live your best life - inside and out.

Better care is here

Live your best life - inside and out.